There are still some kinks to be ironed out, including risks of hemolysis and valve thrombosis, to put things on par with ...
Erlanger Health announces the recent completion of surgeries using new Pulsed Field Ablation (PFA) technology to better treat patients battling atrial fibrillation (AFib). Officials said, "As the ...
EMPAVELI's key market opportunities include its strong differentiation through C3 inhibition, capturing PNH patients inadequately controlled by C5 inhibitors. Expansion into rare kidney diseases, ...
Check approved for trading on Nasdaq First North - Regulatory This Press Release should not be released or distributed, directly or indirectly, within USA, Canada, Japan, Australia ...
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced the submission of ...
Detailed results from RISE UP Phase 3 trial of mitapivat in sickle cell disease selected for distinguished Plenary Abstracts Session; Company to host investor conference call and ...
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal hematopoietic stem cell disease that results in severe and even life-threatening clinical consequences. 1 The disease occurs due to a ...
Preanalytical errors in clinical labs—like hemolysis, contamination, or mislabeling—can derail patient care before testing even begins. These mistakes are most common in high-pressure areas like ...
Abstract: Prolonged and uncontrolled high shear stresses and turbulence can cause hemolysis, while alternating and low-level stresses may contribute to platelet activation and thrombus formation. Such ...
Presented positive clinical data for pociredir, demonstrating robust and rapid fetal hemoglobin (HbF) induction, improvements in markers of hemolysis and anemia, and encouraging trends in vaso-occlusi ...
Presented positive clinical data for pociredir, demonstrating robust and rapid fetal hemoglobin (HbF) induction, improvements in markers of ...